These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37270070)

  • 1. Directions of change in intrinsic case severity across successive SARS-CoV-2 variant waves have been inconsistent.
    Pascall DJ; Vink E; Blacow R; Bulteel N; Campbell A; Campbell R; Clifford S; Davis C; da Silva Filipe A; El Sakka N; Fjodorova L; Forrest R; Goldstein E; Gunson R; Haughney J; Holden MTG; Honour P; Hughes J; James E; Lewis T; MacLean O; McHugh M; Mollett G; Nyberg T; Onishi Y; Parcell B; Ray S; Robertson DL; Seaman SR; Shabaan S; Shepherd JG; Smollett K; Templeton K; Wastnedge E; Wilkie C; Williams T; ; Thomson EC
    J Infect; 2023 Aug; 87(2):128-135. PubMed ID: 37270070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
    Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
    Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H
    JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
    Nyberg T; Ferguson NM; Nash SG; Webster HH; Flaxman S; Andrews N; Hinsley W; Bernal JL; Kall M; Bhatt S; Blomquist P; Zaidi A; Volz E; Aziz NA; Harman K; Funk S; Abbott S; ; Hope R; Charlett A; Chand M; Ghani AC; Seaman SR; Dabrera G; De Angelis D; Presanis AM; Thelwall S
    Lancet; 2022 Apr; 399(10332):1303-1312. PubMed ID: 35305296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: A cohort study and ecological analysis.
    Català M; Coma E; Alonso S; Andrés C; Blanco I; Antón A; Bordoy AE; Cardona PJ; Fina F; Martró E; Medina M; Mora N; Saludes V; Prats C; Prieto-Alhambra D; Alvarez-Lacalle E
    Front Public Health; 2022; 10():961030. PubMed ID: 36033822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 from COVID-19 Patients in the Republic of Moldova: Whole-Genome Sequencing Results.
    Morozov A; Nirca V; Victorova A; Poppert S; Frickmann H; Yamada C; Kacena MA; Rata S; Movila A
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
    PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.
    Bormann M; Brochhagen L; Alt M; Otte M; Thümmler L; van de Sand L; Kraiselburd I; Thomas A; Gosch J; Braß P; Ciesek S; Widera M; Dolff S; Dittmer U; Witzke O; Meyer F; Lindemann M; Schönfeld A; Rohn H; Krawczyk A
    Front Immunol; 2023; 14():1150667. PubMed ID: 37520539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic features of SARS-CoV-2 Alpha, Delta, and Omicron variants and their association with the clinical severity of COVID-19 in Vietnam.
    Van Nam L; Dien TC; Bang LVN; Thach PN; Van Duyet L
    IJID Reg; 2024 Jun; 11():100348. PubMed ID: 38601946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS-CoV-2 variants.
    Ali KM; Rashid PMA; Ali AM; Tofiq AM; Salih GF; Dana OI; Rostam HM
    Eur J Clin Invest; 2023 Sep; 53(9):e14004. PubMed ID: 37036255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and Postacute COVID-19 Outcomes Among Immunologically Naive Adults During Delta vs Omicron Waves.
    Doll MK; Waghmare A; Heit A; Levenson Shakoor B; Kimball LE; Ozbek N; Blazevic RL; Mose L; Boonyaratanakornkit J; Stevens-Ayers TL; Cornell K; Sheppard BD; Hampson E; Sharmin F; Goodwin B; Dan JM; Archie T; O'Connor T; Heckerman D; Schmitz F; Boeckh M; Crotty S
    JAMA Netw Open; 2023 Feb; 6(2):e231181. PubMed ID: 36853602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis.
    Relan P; Motaze NV; Kothari K; Askie L; Le Polain O; Van Kerkhove MD; Diaz J; Tirupakuzhi Vijayaraghavan BK
    BMJ Glob Health; 2023 Jul; 8(7):. PubMed ID: 37419502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes.
    Mondi A; Mastrorosa I; Piselli P; Cimaglia C; Matusali G; Carletti F; Giannico G; Milozzi E; Biliotti E; Di Bari S; Chinello P; Beccacece A; Faraglia F; Vittozzi P; Mosti S; Tetaj N; Stazi GV; Pinnetti C; Camici M; D'Annunzio A; Marani A; Fabeni L; Specchiarello E; Gruber CEM; Villanacci A; Minicucci S; Garbuglia AR; Ianniello S; Marchioni L; Taglietti F; D'Offizi G; Palmieri F; Nicastri E; Maggi F; Vaia F; Girardi E; Antinori A
    J Med Virol; 2023 Jun; 95(6):e28831. PubMed ID: 37246793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study.
    Stock SJ; Moore E; Calvert C; Carruthers J; Denny C; Donaghy J; Hillman S; Hopcroft LEM; Hopkins L; Goulding A; Lindsay L; McLaughlin T; Taylor B; Auyeung B; Katikireddi SV; McCowan C; Ritchie LD; Rudan I; Simpson CR; Robertson C; Sheikh A; Wood R
    Lancet Respir Med; 2022 Dec; 10(12):1129-1136. PubMed ID: 36216011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination.
    Varea-Jiménez E; Aznar Cano E; Vega-Piris L; Martínez Sánchez EV; Mazagatos C; García San Miguel Rodríguez-Alarcón L; Casas I; Sierra Moros MJ; Iglesias-Caballero M; Vazquez-Morón S; Larrauri A; Monge S;
    Enferm Infecc Microbiol Clin (Engl Ed); 2024 Apr; 42(4):187-194. PubMed ID: 36737369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in Scotland.
    Kerr S; Vasileiou E; Robertson C; Sheikh A
    J Glob Health; 2022 Jul; 12():05025. PubMed ID: 35802764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing COVID-19 severity in patients hospitalized for community-associated Delta, BA.1 and BA.4/5 variant infection.
    Sočan M; Mrzel M; Prosenc K; Korva M; Avšič-Županc T; Poljak M; Lunar MM; Zupanič T
    Front Public Health; 2024; 12():1294261. PubMed ID: 38450129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants.
    Trobajo-Sanmartín C; Miqueleiz A; Guevara M; Fernández-Huerta M; Burgui C; Casado I; Baigorria F; Navascués A; Ezpeleta C; Castilla J
    J Infect Dis; 2023 Feb; 227(3):332-338. PubMed ID: 36179126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants.
    Esper FP; Adhikari TM; Tu ZJ; Cheng YW; El-Haddad K; Farkas DH; Bosler D; Rhoads D; Procop GW; Ko JS; Jehi L; Li J; Rubin BP
    J Infect Dis; 2023 Feb; 227(3):344-352. PubMed ID: 36214810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.